argenx SE | ARGX - Sales Revenues

Stock Price
693.20
Daily Change
-1.00 -0.14%
Monthly
-2.45%
Yearly
37.43%
Q2 Forecast
678.23

argenx SE reported $1.12B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
AstraZeneca USD 15.29B 213M Mar/2026
Genmab DKK 1.06B 36M Dec/2025
GlaxoSmithKline GBP 7.63B 991M Mar/2026
GRIFOLS EUR 1.7B 280M Mar/2026
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Lakefront Biotherapeutics EUR 6.5M 894.32M Mar/2026
Qiagen NV USD 419.22M 38.16M Mar/2026
UCB EUR 4.25B 764M Dec/2025